Third generation osimertinib mesylate. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy23

K562 Cells Cells, Cultured Philadelphia Chromosome Cell Line, Tumor Cell Line Fibroblasts Tumor Cells, Cultured Chromosomes, Human, Pair 9 Neoplastic Stem Cells Hematopoietic Stem Cells Myeloid Progenitor Cells HL-60 Cells Skin Dendritic Cells T-Lymphocytes Bone Marrow Cells Bone Marrow Orbit Neutrophils Brain Stromal Cells Neurons Mitochondria

Organisms8

Gram-Negative Bacteria Mice, Inbred C57BL Mice, Inbred BALB C Mice, Knockout Rats, Sprague-Dawley Mice, Transgenic Mice, SCID Rats, Wistar

Diseases38

Ureterolithiasis Thromboembolism Leukemia, Myelogenous, Chronic, BCR-ABL Positive Gastrointestinal Stromal Tumors Hepatitis C Leukemia, Myeloid, Chronic-Phase Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Gastrointestinal Neoplasms Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Philadelphia Chromosome Mastocytosis, Systemic Dermatofibrosarcoma Fibromatosis, Aggressive Lichenoid Eruptions Nausea Leukemia, Myeloid, Accelerated Phase Disease Models, Animal Disease Progression Primary Myelofibrosis Neoplasms Recurrence Neoplasm, Residual Vomiting Thrombocytopenia Neutropenia Histiocytoma, Malignant Fibrous Scleroderma, Systemic Fibrosis Graves Ophthalmopathy Leukemia Anorexia Spinal Cord Neoplasms Neoplasm Metastasis Precursor Cell Lymphoblastic Leukemia-Lymphoma Pulmonary Fibrosis Chromosome Aberrations

Chemicals and Drugs100

Contraceptives, Oral, Synthetic Desogestrel Norpregnenes Benzamides Contraceptives, Oral, Combined Piperazines Pyrimidines Contraceptives, Oral Cephalosporins Anti-Bacterial Agents Hepatitis C Antibodies Aromatase Inhibitors Pregnatrienes Fusion Proteins, bcr-abl beta-Lactamases Antineoplastic Agents Proto-Oncogene Proteins c-kit Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Protein Kinase Inhibitors Receptor, Platelet-Derived Growth Factor beta Deferoxamine Protein-Tyrosine Kinases Ergoloid Mesylates Proto-Oncogene Proteins c-abl Enzyme Inhibitors Mesylates Reactive Oxygen Species Pergolide Fenoldopam Pefloxacin Benzoxazines Delavirdine Tubulin Modulators Receptors, Platelet-Derived Growth Factor Naphthalenes Superoxides Pralidoxime Compounds Quinolizines Nelfinavir Proto-Oncogene Proteins c-sis Gabexate RNA, Messenger Morpholines Pyrroles Free Radical Scavengers Indoles Antimitotic Agents Cannabinoid Receptor Agonists Cannabinoids Ergolines Dihydroergotoxine Bromocriptine Harringtonines mRNA Cleavage and Polyadenylation Factors Dihydroergotamine Interferon-alpha Lipid Peroxides Doxazosin Rifabutin Thiazoles Hydrogen Peroxide Dexamethasone Receptors, Glucocorticoid Platelet-Derived Growth Factor Stem Cell Factor NADPH Oxidase STAT5 Transcription Factor Hydroxyurea Free Radicals Receptors, Cannabinoid Piperidines Phentolamine Thrombin Receptor, Cannabinoid, CB1 Antigens, CD34 Pyrazoles Adrenergic alpha-Antagonists Nitric Oxide Cannabinoid Receptor Antagonists Neoplasm Proteins Iron Chelating Agents Milk Proteins Antiemetics Pyridines Oncogene Proteins, Fusion Camptothecin Benzoquinones Antineoplastic Agents, Phytogenic DNA-Binding Proteins Calcium Naphthyridines Proto-Oncogene Proteins c-bcl-2 Topotecan Affinity Labels src-Family Kinases Lactams, Macrocyclic ATP-Binding Cassette Transporters Imidazoles

Analytical, Diagnostic and Therapeutic Techniques and Equipment48

Treatment Outcome Microbial Sensitivity Tests Risk Factors Pedigree Prevalence Cohort Studies Prospective Studies Case-Control Studies Retrospective Studies Cytogenetic Analysis Drug Approval Remission Induction Administration, Oral Reverse Transcriptase Polymerase Chain Reaction Disease-Free Survival Drug Administration Schedule Blotting, Western Immunohistochemistry Survival Analysis Chromatography, High Pressure Liquid Disease Models, Animal Flow Cytometry Models, Biological In Situ Hybridization, Fluorescence Treatment Failure Prognosis Antineoplastic Combined Chemotherapy Protocols Salvage Therapy Inhibitory Concentration 50 Survival Rate Polymerase Chain Reaction Lymphocyte Activation Transfection Follow-Up Studies Retreatment Maximum Tolerated Dose Blood Cell Count Gene Expression Profiling Crosses, Genetic Transplantation, Homologous DNA Mutational Analysis Combined Modality Therapy Area Under Curve Neoadjuvant Therapy Models, Genetic Clinical Trials as Topic Drug Screening Assays, Antitumor Infusions, Intravenous

Phenomena and Processes41

Time Factors Drug Resistance, Multiple, Bacterial Drug Resistance, Bacterial Drug Resistance, Neoplasm Genes, abl Dose-Response Relationship, Drug Philadelphia Chromosome Mutation Apoptosis Signal Transduction Cell Proliferation Phosphorylation Cell Survival Drug Synergism Kinetics Cell Division Cell Differentiation Enzyme Activation Base Sequence Chromosomes, Human, Pair 9 Gene Expression Phenotype Inhibitory Concentration 50 Lymphocyte Activation Transfection Gene Expression Regulation, Leukemic Amino Acid Sequence Maximum Tolerated Dose Oxidative Stress Down-Regulation Blood Cell Count Oxidation-Reduction Gene Expression Regulation Cell Death Molecular Structure Drug Interactions G0 Phase Area Under Curve Selection, Genetic Up-Regulation Chromosome Aberrations

Disciplines and Occupations2

Immunohistochemistry Cytogenetics

Anthropology, Education, Sociology and Social Phenomena2

Drug Approval United States Food and Drug Administration

Technology, Industry, Agriculture1

Information Science5

Prevalence Molecular Sequence Data Base Sequence Survival Rate Amino Acid Sequence

Named Groups1

Infant, Newborn

Health Care15

Treatment Outcome Risk Factors Prevalence Cohort Studies Prospective Studies Case-Control Studies Retrospective Studies Disease-Free Survival United States Food and Drug Administration Survival Analysis Treatment Failure Survival Rate Follow-Up Studies Area Under Curve Clinical Trials as Topic

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care

Contraceptives, Oral, Synthetic Desogestrel Norpregnenes Benzamides Contraceptives, Oral, Combined Piperazines Ureterolithiasis Pyrimidines Contraceptives, Oral Thromboembolism Cephalosporins Anti-Bacterial Agents Hepatitis C Antibodies Leukemia, Myelogenous, Chronic, BCR-ABL Positive Aromatase Inhibitors Gastrointestinal Stromal Tumors Hepatitis C Treatment Outcome Pregnatrienes Microbial Sensitivity Tests Gram-Negative Bacteria Risk Factors Fusion Proteins, bcr-abl Pedigree Time Factors beta-Lactamases Drug Resistance, Multiple, Bacterial Antineoplastic Agents Drug Resistance, Bacterial Proto-Oncogene Proteins c-kit Prevalence Cohort Studies Prospective Studies Receptor, Platelet-Derived Growth Factor alpha Ketones Furans Case-Control Studies Protein Kinase Inhibitors Leukemia, Myeloid, Chronic-Phase Infant, Newborn Receptor, Platelet-Derived Growth Factor beta Retrospective Studies Hypopigmentation Hypereosinophilic Syndrome Blast Crisis Drug Resistance, Neoplasm Cytogenetic Analysis Deferoxamine Genes, abl Protein-Tyrosine Kinases Ergoloid Mesylates Proto-Oncogene Proteins c-abl Gastrointestinal Neoplasms K562 Cells Enzyme Inhibitors Dose-Response Relationship, Drug Mesylates Cells, Cultured Reactive Oxygen Species Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Pergolide Philadelphia Chromosome Fenoldopam Cell Line, Tumor Drug Approval Remission Induction Mutation Apoptosis Pefloxacin Benzoxazines Signal Transduction Delavirdine Tubulin Modulators Receptors, Platelet-Derived Growth Factor Mastocytosis, Systemic Dermatofibrosarcoma Administration, Oral Naphthalenes Superoxides Cell Line Cell Proliferation Pralidoxime Compounds Phosphorylation Quinolizines Nelfinavir Proto-Oncogene Proteins c-sis Mice, Inbred C57BL Gabexate RNA, Messenger Fibromatosis, Aggressive Morpholines Pyrroles Reverse Transcriptase Polymerase Chain Reaction Cell Survival Free Radical Scavengers Drug Synergism Indoles Antimitotic Agents Disease-Free Survival Drug Administration Schedule

No FAQ available that match "third generation osimertinib mesylate"